Ocugen, Inc. (OCGN)
1.38
+0.02
(+1.47%)
USD |
NASDAQ |
Dec 15, 16:00
1.41
+0.03
(+2.17%)
After-Hours: 06:35
Ocugen Research and Development Expense (Annual): 30.16M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Belite Bio, Inc. | 29.94M |
| MannKind Corp. | 45.89M |
| Vertex Pharmaceuticals, Inc. | 3.630B |
| CorMedix, Inc. | 3.942M |
| Verastem, Inc. | 81.33M |